Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-19-002023)

Filing Details

Accession Number:: 0001562180-19-002023
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-03-25 16:03:30
Reporting Period:: 2019-03-21

Accepted Time:: 2019-03-25 16:03:30
Original Submission Date:: 2019-03-22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1395937	Syndax Pharmaceuticals Inc	SNDX	Pharmaceutical Preparations (2834)	320162505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664204	L. Michael Meyers	C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451	Svp, Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-21	8	$4.87	7,230	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Amendment filed to correct previously filed Form, which did not include 8 shares purchased in an additional transaction.